Maritime Ambulance Service Launches on Egypt's Mediterranean Coast
A maritime ambulance service has begun operations, with locally manufactured vessels providing emergency care at sea.
May 25, 2025
A new maritime ambulance service has officially launched on the Mediterranean coast. The announcement was made during the celebration of the 123rd anniversary of the Egyptian Ambulance Authority.
Three sea ambulances have been deployed along Egypt's northern coast, each equipped with intensive care units, advanced communication systems, and medical equipment designed for rapid response in offshore emergencies. The vessels are intended to enhance Egypt's ability to provide medical assistance in maritime environments, including for individuals on commercial ships, fishing boats, and tourist vessels.
"We have launched the marine ambulance service for the first time in the Arab Republic of Egypt with a force of three marine ambulances that were manufactured and fully equipped inside Egypt to provide ambulance services on the Egyptian coasts, out of six ambulances that are being manufactured in cooperation with the Suez Canal Authority,' Prime Minister Dr Mostafa Madbouly said during the announcement. 'The mobile phone application, Esaafni, was also launched to enable citizens to easily request non-emergency services in 13 governorates.'
Officials from the Egyptian Ambulance Authority confirmed that the three ambulances were designed and constructed in Egypt, supporting national industry while meeting international safety and medical standards.
The maritime ambulances will operate in coordination with coastal emergency centres, under the unified emergency number 123.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Al-Ahram Weekly
18 minutes ago
- Al-Ahram Weekly
During World Thyroid Awareness Week: Merck Launches a New Dosage of Euthyrox 75 Micrograms - Sponsored
As part of its ongoing efforts to raise awareness about thyroid-related diseases, Merck Limited Egypt announced the launch of a new dosage of 'Euthyrox 75 micrograms' in the Egyptian market. This announcement was made during the events of the International Thyroid Awareness Week on May 30, 2025, with the participation of 350 healthcare professionals from across Egypt, in addition to 14 expert speakers and session chairs in the field of endocrinology. Hypothyroidism is one of the most common diseases affecting millions worldwide. Patients suffer from reduced thyroid gland activity, which leads to a drop in thyroid hormone levels in the body. Thyroid disorders are among the most widespread endocrine disorders globally, ranking second only to diabetes, with up to 10% of the population affected—making it a major public health concern. It is also one of the leading causes of fatigue, weight gain, depression, heart problems, and other symptoms. Through this event, Merck aimed to raise awareness about the importance of early diagnosis and effective treatment of thyroid disorders. Treatment using synthetic thyroid hormones such as 'Euthyrox' can help restore hormonal balance. Merck is considered a leading company in the field of healthcare and is committed to its social and medical responsibility toward patients with hypothyroidism. With the launch of the new 75 microgram dosage of 'Euthyrox,' the company reaffirms its ongoing support for patients. Dr. Ibrahim Naguib Al-Ebeirashy, Professor of Internal Medicine and Endocrinology at Qasr Al-Ainy and former Head of Internal Medicine Departments at Qasr Al-Ainy, stated that the availability of the 75 microgram dosage of Euthyrox will benefit patients who require precise dose adjustments to avoid hormonal fluctuations. Dr. Sherif El-Seddawy, General Manager and Executive Director of Merck, confirmed that the launch of the new 'Euthyrox 75 micrograms' dosage reflects continued support for patients, alongside the company's commitment to raising awareness about hypothyroidism. He emphasized Merck's ongoing efforts to accelerate scientific and medical initiatives for the benefit of patients. Furthermore, Merck Limited Egypt praised and appreciated the Egyptian Drug Authority as a strategic partner for its ongoing collaboration and efforts to increase awareness among patients and physicians. Dr. Cyrine Hammami, Regional Head of Cardiometabolic and Endocrine Diseases for the Middle East, Africa, and Russia, expressed the company's pride in launching Euthyrox 75 micrograms in the Egyptian market, emphasizing that raising awareness about hypothyroidism is an important step for the community. In this context, Dr. Mohamed Ismail, Head of the Cardiometabolic and Endocrine Business Unit at Merck Limited Egypt, stated that offering multiple dosage options, such as 75 micrograms, helps patients avoid the complications of manual dose adjustment. Dr. Rania Rafiq, Medical Affairs Director, highlighted that raising awareness about hypothyroidism remains one of the company's top priorities, especially since the symptoms can be vague and often diagnosed only after long periods of suffering. Therefore, shedding light on this occasion is of great importance. Follow us on: Facebook Instagram Whatsapp Short link:
Daily News Egypt
12 hours ago
- Daily News Egypt
Haleon captures over 20% market share in Egypt, locally manufactures 90% of product portfolio
Haleon, the global consumer health leader, has reinforced its footprint in Egypt following its demerger from GSK in July 2022. The company now holds over 20% of Egypt's consumer health market and manufactures approximately 90% of its flagship brands locally, according to Asif Alavi, General Manager for North Africa at Haleon. Speaking to Daily News Egypt, Alavi said that local production covers trusted household names such as Sensodyne, Parodontax, Panadol, Otrivin, and Voltaren Emulgel, underscoring Haleon's commitment to supply chain resilience and economic contribution through technology transfer and export capabilities. Egypt serves as a key regional base for exports to the Maghreb, Gulf countries, and Saudi Arabia. Alavi emphasized that local manufacturing has helped shield the company from global economic volatility, including inflation, currency fluctuations, and supply chain disruptions. 'Our strategy has significantly minimized exposure to global shocks, enabling us to maintain stability and accessibility in the Egyptian market,' he noted. Globally, Haleon is advancing its innovation pipeline, including a £130m investment in a new Global Oral Health Innovation Centre in Weybridge, UK, slated to open in 2027. The facility will support Haleon's category leadership in oral health and accelerate R&D for key brands like Sensodyne, which Alavi described as resilient due to its therapeutic value and strong dentist recommendations—even during economic downturns. Recognizing the price sensitivity in emerging markets, Haleon has adopted a multi-format, tiered pricing strategy to ensure broad accessibility. The company also champions self-care as a cornerstone of sustainable healthcare. Alavi cited research by the Global Self-Care Federation, which estimates self-care interventions have already delivered $119bn in global healthcare cost savings and $1.9trn in welfare gains—figures projected to rise to $179bn and $2.8trn, respectively. Looking ahead, Alavi reaffirmed Haleon's long-term vision in Egypt: 'We are committed to being a core contributor to the Egyptian healthcare ecosystem—by making everyday health more accessible, inclusive, and sustainable.'
Mada
15 hours ago
- Mada
Politicians, students, 130 former prisoners call for Sisi to release Alaa Abd El Fattah immediately
Urgent appeals have mounted in the last hours for the immediate release of detained activist and writer, Alaa Abd El Fattah, as his mother Laila Soueif lies in hospital in London, 245 days into a hunger strike. Egyptian authorities have imprisoned Abd El Fattah since 2019, in what United Nations experts ruled last week is arbitrary detention. Among those calling for his release are nearly 130 former prisoners, all of whom faced similar charges to Abd El Fattah in relation to their political views, and who issued a statement on Saturday calling for the writer's release 'today, not tomorrow,' in a plea to 'end the suffering of his family and save the life of his mother.' Soueif's blood sugar dropped dangerously low on Thursday night and she was hospitalized. Doctors say her life is in immediate danger. The prisoners' statement was shared by activist Ahmed Douma, who spent a decade in prison for participating in protests before he was granted presidential amnesty in 2023, and by lawyer and activist Mahienour al-Massry who was detained in 2018 while advocating for the release of detainees imprisoned for their political convictions. All signatories to the appeal faced charges similar to Abd El Fattah's, the statement said, including spreading false news, unlawful assembly, joining a terrorist group 'or other charges tied to freedom of expression and public participation.' The statement voiced deep concern over the decline in Soueif's health. 'In her perseverance,' it read, 'resounds the perseverance of hundreds of families worn down by imprisonment, and the stories of parents, siblings and children who have tried to make their voices heard only to be met with a wall of silence.' Soueif has made repeated appeals, both to the Public Prosecution and to leaders in both Egypt and the United Kingdom, where she and her family hold second nationality. In their statement, which remained open for additional signatories, the former prisoners called on authorities to 'reconsider the cases of all political prisoners.' 'We urge the relevant authorities in the Egyptian state to act with the wisdom and responsibility that this critical historical moment demands — and to release Alaa Abd El Fattah, in whatever form they see fit, in a way that befits a strong nation capable of correcting its course without hesitation,' the statement read. The signatories argued that releasing Abd El Fattah would do no harm to the state, just as their own releases 'have not posed any threat to public safety.' Instead, their release was welcomed both domestically and internationally as 'a reflection of a maturing state that comprehends the moment,' the statement added. Soueif, a mathematics professor at Cairo University, is on hunger strike to call for her son's release in 2024. The writer's sentence was due to come to an end in September but prosecutors refused the families' petitions to credit the two years he spent in remand detention toward his final sentence. The Civil Democratic Movement, a coalition of liberal parties, also called for Abd El Fattah's release at a press conference held Sunday at the headquarters of the Conservative Party. The politicians said that the power to release Abd El Fattah lay in the President's hands, urging him to include Abd El Fattah, alongside others imprisoned for freedom of expression, in general amnesty lists released for Eid al-Adha. Lawyer Suzanne Nady, who was in attendance, questioned what more must happen before Egyptian authorities begin upholding the law. 'We've already exhausted every peaceful route,' she said. Cairo University students submitted their own urgent appeal on Sunday to university president Mohamed Samy Abdel Sadek to intervene and save Soueif's life, who they said 'continued to fulfill her academic and teaching responsibilities at the university with unwavering dedication, up until the moment she departed for London.' The statement, a copy of which Mada Masr reviewed, called for Abdel Sadek to address the president and relevant authorities to secure Abd El Fattah's release 'in recognition of what [Soueif] offered and continues to offer to the university and Egypt's scientific community.' Over the past months, Soueif has repeatedly appealed to authorities in both Egypt and the United Kingdom. But 'nothing has changed,' Soueif said in a statement two weeks ago, announcing her decision to resume a full hunger strike after she had temporarily increased her intake to include a 300-calorie liquid supplement daily in March at the advice of doctors. British Prime Minister Keir Starmer last contacted President Abdel Fattah al-Sisi regarding Abd El Fattah's case on May 22. Though Soueif acknowledged Starmer's intentions in her announcement that she would resume a full hunger strike, she concluded that 'nothing is happening' to release her son. 'We have used up more days than we ever thought we had. We need Alaa released now.'
